True Wealth Design’s Nuvation Bio NUVB Stock Holding History

True Wealth Design’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.31K	Sell	1,111 -3	-0.3%	-$15	﹤0.01%	1238
2026 Q1	$4.78K	Hold	1,114	–	–	﹤0.01%	1232
2025 Q4	$9.98K	Hold	1,114	–	–	﹤0.01%	868
2025 Q3	$4.12K	Buy	1,114 +387	+53%	+$1.05K	﹤0.01%	1156
2025 Q2	$1.42K	Buy	727 +709	+3,939%	+$1.48K	﹤0.01%	1321
2025 Q1	$32	Sell	18 -48	-73%	-$109	﹤0.01%	2499
2024 Q4	$176	Sell	66 -495	-88%	-$1.27K	﹤0.01%	1234
2024 Q3	$1.28K	Buy	+561	New	+$1.71K	﹤0.01%	908

Other funds holding NUVB

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

FWP

Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

True Wealth Design's NUVB Position: Q2 2026 in Review

True Wealth Design reduced its Nuvation Bio (NUVB) stake by 0.27% in Q2 2026, selling an estimated $15 and leaving 1,111 shares worth $6.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

True Wealth Design first reported a position in NUVB in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.98K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

True Wealth Design held 1,111 shares of Nuvation Bio worth $6.31K as of Q2 2026.
True Wealth Design sold 3 Nuvation Bio shares in Q2 2026, an estimated $15.
Nuvation Bio made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1238 holding.
True Wealth Design first reported a position in Nuvation Bio in Q3 2024 and has held it in 8 quarters since.
True Wealth Design's Nuvation Bio position peaked at $9.98K in Q4 2025.
13 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.